| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |